Skip to search.
 FTSE 100 Up 1.33%

Sangamo BioSciences, Inc. (SGMO)

-NasdaqGS
3.00 Down 0.10(3.23%) 6 Dec 21:00
|Pre-Market : 3.00 0.00 (0.00%) 22:20 - Nasdaq Real Time Price
Prev Close:3.10
Open:N/A
Bid:2.15 x 100
Ask:3.35 x 100
1y Target Est:7.00
Beta:2.94223
Earnings Date:7 Feb - 13 Feb (Est.)
Day's Range:N/A - N/A
52wk Range:2.90 - 9.83
Volume:0
Avg Vol (3m):900,542
Market Cap:211.87m
P/E (ttm):N/A
EPS (ttm):-1.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMODown 3.23%211.87m
LLYUp 0.80%71.55b
AMGNDown 0.12%107.95b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.14
Quarterly EPS Est (Dec-16) :-0.25
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback